Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

unknown1
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases

NCT04520737
completednot_applicable

Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery

NCT04498208
unknownnot_applicable

Prehabilitation to Improve Cancer Surgery Outcomes

NCT03502317

Clinical Trials (3)

Showing 3 of 3 trials
NCT04520737Not Applicable

Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases

Recruiting
NCT04498208Not Applicable

Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery

Completed
NCT03502317Not Applicable

Prehabilitation to Improve Cancer Surgery Outcomes

Unknown

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3